Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer (Q30497303)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer |
scientific article |
Statements
1 reference
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer (English)
1 reference
Bradley J Monk
1 reference
Ernest S Han
1 reference
Robert A Burger
1 reference
Kathleen M Darcy
1 reference
Michael W Sill
1 reference
Leslie M Randall
1 reference
Dana Chase
1 reference
Basmina Parmakhtiar
1 reference
Benjamin E Greer
1 reference
Patrick Connelly
1 reference
Koen Degeest
1 reference
John P Fruehauf
1 reference
25 September 2010
1 reference
1 reference
119
1 reference
484-490
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference